Moneycontrol

Budget 2023Budget 2023

PARTNERS

  • Tata AIA Life Insurance
  • Hafele
  • Motilal Oswal
  • SMC Global Securities Limited
  • SBI Life
  • DSP Mutual Fund
Upcoming Event : LeapToUnicorn - mentoring, networking and fundraising for startups. Register now
you are here: HomeNewsIndia

India's involvement can make treatment mainstream, says CAR-T therapy pioneer

The CAR-T therapy costs about $1 million - $1.5 million, including administration and hospitalisation costs in US.

February 25, 2020 / 04:02 PM IST

India can help solve the accessibility problem of breakthrough cancer treatment CAR -T Cell therapy, according to American physician scientist Carl June.

CAR-T therapies have been effective against certain types of blood cancer. However, the treatment remained inaccessible to most patients due to its  cost.

The CAR-T therapy costs about $1 million - $1.5 million, including administration and hospitalisation costs in US.

Novartis charges Kymriah - its CAR-T therapy about $475,000 for acute lymphoblastic leukemia (ALL).